Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Judith M. Healy"'
Autor:
Thomas V. Holohan, Christopher J. Horvath, Tia DeFeo-Fraulini, H. Nicholas Marsh, Robert G. Schaub, Sleiman BouFakhreddine, James C. Gilbert, Judith M. Healy, Renta Hutabarat, Patricia G. Merlino
Publikováno v:
Circulation. 116:2678-2686
Background— ARC1779 is a therapeutic aptamer antagonist of the A1 domain of von Willebrand Factor (vWF), the ligand for receptor glycoprotein 1b on platelets. ARC1779 is being developed as a novel antithrombotic agent for use in patients with acute
Autor:
Markus Kurz, Charles Wilson, Scott D. Lewis, Kristin Thompson, Judith M. Healy, Thomas Green Mccauley, Ryan M. Boomer
Publikováno v:
Pharmaceutical Research. 21:2234-2246
Aptamers are highly selective nucleic acid-based drugs that are currently being developed for numerous therapeutic indications. Here, we determine plasma pharmacokinetics and tissue distribution in rat of several novel aptamer compositions, including
Publikováno v:
Protein & Peptide Letters. 5:185-191
Abstract: The M. tuberculosis rpoA gene, encoding the a subunit of RNA polymerase, was isolated by a polymerase chain reaction-based strategy using primers directed against regions of a that are highly conserved among Gram-positive and Gram-negative
Publikováno v:
Protein & Peptide Letters. 3:23-30
Abstract: We have selected RGD peptides recognized efficiently by integrin av3 through randomization of amino acids flanking the RGD motif. Degenerate RGD peptides were displayed on phage as fusions to the N-terminus of major coat protein Vill of M13
Publikováno v:
ChemInform. 39
Aptamers are non-naturally occurring structured oligonucleotides that may bind to small molecules, peptides, and proteins. Typically, aptamers are generated by an in vitro selection process referred to as SELEX (systematic evolution of ligands by exp
Publikováno v:
Accounts of chemical research. 41(1)
Aptamers are non-naturally occurring structured oligonucleotides that may bind to small molecules, peptides, and proteins. Typically, aptamers are generated by an in vitro selection process referred to as SELEX (systematic evolution of ligands by exp
Publikováno v:
The Aptamer Handbook: Functional Oligonucleotides and Their Applications
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e23e7c0974876e18807e9d327563a51c
https://doi.org/10.1002/3527608192.ch17
https://doi.org/10.1002/3527608192.ch17
Publikováno v:
Journal of biomolecular techniques : JBT. 16(3)
In the simplest view, aptamers can be thought of as nucleic acid analogs to antibodies. They are able to bind specifically to proteins, and, in many cases, that binding leads to a modulation of protein activity. New aptamers are rapidly generated thr
Autor:
Ryan M. Boomer, Markus Kurz, Scott D. Lewis, Thomas Green Mccauley, Charles Wilson, Judith M. Healy
Publikováno v:
Oligonucleotides. 15(3)
Here, we examine biodistribution of radiolabeled aptamers and assess the relative ability of different stabilized aptamer compositions (mixed 2'-F/2'-O-Me; fully 2'-O-Me modified) to access inflamed tissues in a murine inflammation model. Biodistribu
Autor:
Judith M Healy, Paul Dugdale
Publikováno v:
Medical Journal of Australia. 188:549-550